fundvisualizer.com

Morgan Stanley Inst EMkts Ldrs AMELAX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2022
Stock
6.97%
Non-U.S. Stock
88.37%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
4.67%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2022

Basic materials

4.38%

Consumer cyclical

28.33%

Financial services

30.26%

Real estate

0.00%

Consumer defensive

6.09%

Health care

0.55%

Utilities

0.00%

Communication services

0.00%

Energy

0.00%

Industrials

8.67%

Technology

17.06%

Top 10 holdings

As of 12/31/2022

Li Ning Co Ltd
7.58%
MercadoLibre Inc
7.50%
Bajaj Finance Ltd
6.49%
Shenzhou International Group Holdings Ltd
6.19%
ICICI Bank Ltd
5.72%
Chailease Holding Co Ltd
5.37%
AU Small Finance Bank Ltd
5.21%
Globant SA
5.17%
Morgan Stanley Instl Lqudty Govt Ptcpt
4.67%
Proya Cosmetics Co Ltd Class A
4.49%
Fund assets

$312.51 Million

Share class

A

Morningstar category

Diversified Emerging Mkts

Expense ratio

1.37%

Investment objective

Diversified Emerging Markets

Documents